phase readout
saveNCT07371338: Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients
RECRUITINGupdated 11h ago
community read0 votes
Sponsor: Innopeutics Corporation. Phase: PHASE1. Conditions: Parkinson Disease, Parkinson's Disease
view source ↗
comments(0)
5-min edit window · permanent after that